Cargando…

A Review of Virus-Like Particle-Based SARS-CoV-2 Vaccines in Clinical Trial Phases

The Coronavirus disease 2019 (COVID-19) pandemic has affected more than 269 million worldwide, with more than five million deaths as of early December 2021. The main concerns in this pandemic include the asymptomatic nature of COVID-19, leading to the infection of many healthy people, the infectious...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sharifzadeh, Mohammad, Mottaghi-Dastjerdi, Negar, Soltany Rezae Raad, Mohammad
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Brieflands 2022
Materias:	Review Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9293385/ https://www.ncbi.nlm.nih.gov/pubmed/35873011 http://dx.doi.org/10.5812/ijpr-127042

Ejemplares similares

ChAdOx1 nCoV-19 Vaccine and Thrombosis with Thrombocytopenia Syndrome among Adults: A Systematic Review
por: Faghihi, Homa, et al.
Publicado: (2023)

Genome expression analysis by suppression subtractive hybridization identified overexpression of Humanin, a target gene in gastric cancer chemoresistance
por: Mottaghi-Dastjerdi, Negar, et al.
Publicado: (2014)

Overexpression of FOXO3, MYD88, and GAPDH Identified by Suppression Subtractive Hybridization in Esophageal Cancer Is Associated with Autophagy
por: Soltany-Rezaee-Rad, Mohammad, et al.
Publicado: (2014)

A perspective on SARS-CoV-2 virus-like particles vaccines
por: Gao, Xiaoyang, et al.
Publicado: (2023)

Nanoparticle and virus-like particle vaccine approaches against SARS-CoV-2
por: Kim, Chulwoo, et al.
Publicado: (2022)

Construction of SARS-CoV-2 virus-like particles in plant
por: Moon, Ki-Beom, et al.
Publicado: (2022)

Design and characterization of chimeric Rabies-SARS-CoV-2 virus-like particles for vaccine purposes
por: Garay, Ernesto, et al.
Publicado: (2023)

Minimal system for assembly of SARS-CoV-2 virus like particles
por: Swann, Heather, et al.
Publicado: (2020)

Production of SARS-CoV-2 Virus-Like Particles in Insect Cells
por: Mi, Youjun, et al.
Publicado: (2021)

A scalable and highly immunogenic virus‐like particle‐based vaccine against SARS‐CoV‐2
por: Mohsen, Mona O., et al.
Publicado: (2021)

Efficacy and safety of an inactivated virus-particle vaccine for SARS-CoV-2, BIV1-CovIran: randomised, placebo controlled, double blind, multicentre, phase 3 clinical trial
por: Mohraz, Minoo, et al.
Publicado: (2023)

On the deformation and frequency analyses of SARS-CoV-2 at nanoscale
por: Dastjerdi, Shahriar, et al.
Publicado: (2022)

Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
por: Xu, Ruodan, et al.
Publicado: (2020)

Structural stability of SARS-CoV-2 virus like particles degrades with temperature
por: Sharma, A., et al.
Publicado: (2021)

Cetylpyridinium chloride promotes disaggregation of SARS-CoV-2 virus-like particles
por: Bañó-Polo, Manuel, et al.
Publicado: (2022)

Optimized production and fluorescent labeling of SARS-CoV-2 virus-like particles
por: Gourdelier, Manon, et al.
Publicado: (2022)

PRAK-03202: A triple antigen virus-like particle vaccine candidate against SARS CoV-2
por: Mazumder, Saumyabrata, et al.
Publicado: (2021)

Influenza Virus-like Particle (VLP) Vaccines Expressing the SARS-CoV-2 S Glycoprotein, S1, or S2 Domains
por: Chu, Ki-Back, et al.
Publicado: (2021)

Immunogenicity and Efficacy of Monovalent and Bivalent Formulations of a Virus-Like Particle Vaccine against SARS-CoV-2
por: Resch, Matthew D., et al.
Publicado: (2022)

ESCRT recruitment to SARS-CoV-2 spike induces virus-like particles that improve mRNA vaccines
por: Hoffmann, Magnus A.G., et al.
Publicado: (2023)

SARS-CoV-2 Virus-Like Particle Neutralizing Capacity in Blood Donors Depends on Serological Profile and Donor-Declared SARS-CoV-2 Vaccination History
por: Drews, Steven J., et al.
Publicado: (2022)

Erythema multiform-like lesions in a patient infected with SARS-CoV-2: a case report
por: Fathi, Yaser, et al.
Publicado: (2021)

A chimeric MERS-CoV virus-like particle vaccine protects mice against MERS-CoV challenge
por: Park, Jung-Eun, et al.
Publicado: (2022)

Development of a Vaccine against SARS-CoV-2 Based on the Receptor-Binding Domain Displayed on Virus-Like Particles
por: Zha, Lisha, et al.
Publicado: (2021)

An RBD virus-like particle vaccine for SARS-CoV-2 induces cross-variant antibody responses in mice and macaques
por: Li, Yuanyuan, et al.
Publicado: (2023)

Pseudotyping Improves the Yield of Functional SARS-CoV-2 Virus-like Particles (VLPs) as Tools for Vaccine and Therapeutic Development
por: Zak, Andrew J., et al.
Publicado: (2023)

Corrigendum: Construction of SARS-CoV-2 Virus-Like Particles by Mammalian Expression System
por: Xu, Ruodan, et al.
Publicado: (2020)

Rapid assessment of SARS-CoV-2–evolved variants using virus-like particles
por: Syed, Abdullah M., et al.
Publicado: (2021)

Author Correction: Minimal system for assembly of SARS-CoV-2 virus like particles
por: Swann, Heather, et al.
Publicado: (2021)

SARS-CoV-2 virus-like-particles via liposomal reconstitution of spike glycoproteins
por: McColman, Sarah, et al.
Publicado: (2023)

Genomic Surveillance of SARS-CoV-2 Viruses Collected during the Ending Phase of the First Wave of the COVID-19 Pandemic in Bangladesh
por: Jahan, Munira, et al.
Publicado: (2021)

Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 Viruses
por: Bommireddy, Ramireddy, et al.
Publicado: (2022)

Safety and immunogenicity of an inactivated virus particle vaccine for SARS-CoV-2, BIV1-CovIran: findings from double-blind, randomised, placebo-controlled, phase I and II clinical trials among healthy adults
por: Mohraz, Minoo, et al.
Publicado: (2022)

Enhancing Anti-SARS-CoV-2 Neutralizing Immunity by Genetic Delivery of Enveloped Virus-like Particles Displaying SARS-CoV-2 Spikes
por: Yang, Yongping, et al.
Publicado: (2023)

Increased neutralization potency and breadth elicited by a SARS-CoV-2 mRNA vaccine forming virus-like particles
por: Zhang, Peng, et al.
Publicado: (2023)

A systems biology approach to pathogenesis of gastric cancer: gene network modeling and pathway analysis
por: Mottaghi-Dastjerdi, Negar, et al.
Publicado: (2023)

SARS-CoV-2 virus: Vaccines in development
por: Huang, Qingrui, et al.
Publicado: (2021)

A Capsid Virus-Like Particle-Based SARS-CoV-2 Vaccine Induces High Levels of Antibodies and Protects Rhesus Macaques
por: Volkmann, Ariane, et al.
Publicado: (2022)

Food products as potential carriers of SARS-CoV-2
por: Yekta, Reza, et al.
Publicado: (2021)

Identifying SARS-CoV Membrane Protein Amino Acid Residues Linked to Virus-Like Particle Assembly
por: Tseng, Ying-Tzu, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_gb477f8mgh34con804p96e875c